Systematic selection of screening participants by risk score in a chlamydia screening programme is feasible and effective

Sexually Transmitted Infections

Volumn 88, Issue 3, 2012, Pages 205-211

  Van Den Broek, Ingrid V F ^a   Brouwers, Elfi E H G ^b   Gotz, Hannelore M ^c   Bergen, Jan E A Mvan ^d   Op De Coul, Eline L M ^a   Fennema, Johannes S A ^e   Koekenbier, Rik H ^e   Pars, Lydia L ^d   Van Ravesteijn, Sander M ^c   Hoebe, Christian J P A ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b South Limburg Public Health Service   (Netherlands)

^c Rotterdam Rijnmond Public Health Service   (Netherlands)

^d National Institute for STI and AIDS Control in the Netherlands   (Netherlands)

^e Health Service Amsterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA SCREENING PROGRAM; CHLAMYDIASIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SCREENING TEST; SEXUAL BEHAVIOR; SOCIAL PARTICIPATION;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COMMUNICABLE DISEASE CONTROL; FEMALE; HUMANS; MALE; MASS SCREENING; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; RURAL POPULATION; YOUNG ADULT;

EID: 84860331450     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050219     Document Type: Article

References (30)

1. European Centre for Disease Prevention and Control. Sexually Transmitted Infections in Europe, 1990-2009. Stockholm: ECDC, 2011.
2. Vriend HJ, Koedijk FDH, van den Broek IVF, et al. Sexually Transmitted Infections, Including HIV, in the Netherlands in 2010. RIVM report 210261009. 2011. http:// www.rivm.nl/Thema-s/Infectieziekten/Soa (accessed Oct 2011).
3. Batteiger BE, Xu F, Johnson RE, et al. Protective immunity to Chlamydia trachomatis genital infection: Evidence from human studies. J Infect Dis 2010;201 (Suppl 2):S178-89. Review.
4. Geisler WM. Duration of untreated, uncomplicated genital Chlamydia trachomatis infection and factors associated with chlamydia resolution: A review of human studies. J Infect Dis 2010;201(Suppl 2):S104-13.
5. Low N, Bender N, Nartey L, et al. Effectiveness of chlamydia screening: Systematic review. Int J Epidemiol 2009;38:435-48.
6. van Bergen JE, Fennema JS, van den Broek IV, et al. Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands. BMC Infect Dis 2010;10:293.
7. van den Broek IV, Hoebe CJ, van Bergen JE, et al. Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: Implications of first results for the analysis. BMC Infect Dis 2010;10:89.
8. van Bergen JE, Götz HM, Richardus JH, et al; PILOT CT study group. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: Results from the first national population based study in the Netherlands. Sex Transm Infect 2005;81:17-23. (Pubitemid 40222861)
9. Götz HM, van Bergen JE, Veldhuijzen IK, et al. A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect 2005;81:24-30. (Pubitemid 40222862)
10. Nelson HD, Helfand M. Screening for chlamydial infection. Am J Prev Med 2001;20 (Suppl 3):95-107. (Pubitemid 33732973)
11. Rembold CM. Number needed to screen: Development of a statistic for disease screening. BMJ 1998;317:307-12. Review. (Pubitemid 28353824)
12. Op de Coul ELM, Weenen TC, van der Sande MAB, et al. Process Evaluation of the Chlamydia Screening Implementation in the Netherlands: Phase 1. RIVM Report 210261006/2009. http://www.rivm.nl/Thema-s/Infectieziekten/Soa (accessed May 2011).
13. GGD Amsterdam. Health-Monitor Report 2008. 'Zo gezond is Amsterdam'. 2009. http://www.gezond.amsterdam.nl/Beleid-onderzoekepreventie/ Gezondheidsmonitors/ Amsterdamse-Gezondheidsmonitor/AGM-2008/Bijlagen-AGM-2008- Eindrapport (accessed Oct 2011).
14. GGD Rotterdam-Rijnmond. Monitor Seksuele Gezondheid. http://www. ggdrotterdamrijnmond.nl/onderzoek/professionals/monitor-seksuele-gezondheid. html (accessed Oct 2011).
15. Low N, Egger M. What should we do about screening for genital chlamydia? Int J Epidemiol 2002; 31: 891-3. (Pubitemid 35446857)
16. Hart GJ, Duncan B, Fenton KA. Chlamydia screening and sexual health. Sex Transm Infect 2002;78:396-7. (Pubitemid 36020810)
17. van Valkengoed IG, Morré SA, van den Brule AJ, et al. Low diagnostic accuracy of selective screening criteria for asymptomatic Chlamydia trachomatis infections in the general population. Sex Transm Infect 2000;76:375-80.
18. Marrazzo JM, Fine D, Celum CL, et al. Selective screening for Chlamydial infection in women: A comparison of three sets of criteria. Fam Plann Perspect 1997;29:158-62.
19. Marrazzo JM, Celum CL, Hillis SD, et al. Performance and cost-effectiveness of selective screening criteria for chlamydia trachomatis infection in women. Implications for a national chlamydia control strategy. Sex Transm Dis 1997;24:131-41. (Pubitemid 27123188)
20. Gaydos CA, Dwyer K, Barnes M, et al. Internet-based screening for Chlamydia trachomatis to reach non-clinic populations with mailed self-administered vaginal swabs. Sex Transm Dis 2006;33:451-7. Erratum in: Sex Transm Dis 2007;34:625. (Pubitemid 43964756)
21. Hocking JS, Temple-Smith M, Poznznski S, et al; ACCEPt Consortium. Australian chlamydia control effectiveness pilot: Preliminary results from a trial of chlamydia testing in general practice. Poster at the ISSTDR Conference, 10-13 July 2011, Quebec, Canada. Sex Transm Infect 2011;87:A202.
22. NCSP. NCSP Annual Report 2008-2009. 2009. http://www.chlamydiascreening. nhs.uk (accessed Aug 2011).
23. Meining A, Bayerdörffer E, Müller P, et al. Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 1998;432:311-14. (Pubitemid 28171992)
24. Meining A, Kompisch A, Stolte M. Comparative classification and grading of Helicobacter pylori gastritis in patients with gastric cancer and patients with functional dyspepsia. Scand J Gastroenterol 2003;38: 707-11. (Pubitemid 36920491)
25. Lindström J, Tuomilehto J. The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26:725-31. (Pubitemid 36929335)
26. Jones R, Menon-Johansson A, Waters AM, et al. eTriageea novel, web-based triage and booking service: Enabling timely access to sexual health clinics. Int J STD AIDS 2010;21:30-3.
27. Pittrof R, McLellan J. Test Not Talk screening for asymptomatic men. Int J STD AIDS 2007;18:274-5. (Pubitemid 351739030)
28. Tideman RL, Chen MY, Pitts MK, et al. A randomised controlled trial comparing computer-assisted with face-to-face sexual history taking in a clinical setting. Sex Transm Infect 2007;83:52-6. (Pubitemid 46293806)
29. Yeung A, Bush M, Cummings R, et al. Use of computerized medical records to determine the feasibility of testing for chlamydia without patients seeing a practitioner. Int J STD AIDS 2010;21:755-7.
30. Bilardi JE, Sanci LA, Fairley CK, et al. The experience of providing young people attending general practice with an online risk assessment tool to assess their own sexual health risk. BMC Infect Dis 2009;9:29.